Key Takeaway: MiMedx Group, Inc. (MDXG) announced a favorable legal ruling where the Eleventh Circuit Court of Appeals upheld the dismissal of a securities class action lawsuit filed against the company in 2019. The lawsuit alleged violations of federal securities laws. Following the ruling, MIMEDX's General Counsel expressed optimism about the company's commitment to innovation in patient care and wound management. This decision alleviates potential legal concerns, allowing MIMEDX to focus on its growth in the healthcare market.
Price reaction · baseline $6.61 (2023-07-10 close) · hit after-hours · clean, no other MDXG news in the window
day 0 close · peak
-1.4%
Market Sentiment Analysis
POSITIVE FACTORS
The Eleventh Circuit Court of Appeals affirmed the dismissal of the lawsuit.
The ruling allows MIMEDX to continue focusing on innovation and patient care.
Management expressed satisfaction with the court's decision, which can boost investor confidence.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Cash runway
~40 mo
Low dilution risk
Lead asset
Micronized DHACM
Phase 3 · Tendonitis;Achilles
Full Press Release Details
MARIETTA, Ga., July 11, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that the Eleventh Circuit Court of Appeals affirmed the dismissal of the putative securities class action lawsuit brought against the Company and others in 2019. In the action, the plaintiff claimed that the Company violated federal securities laws. The case was on appeal from the United States District Court for the Northern District of Georgia.
William “Butch” Hulse, MIMEDX General Counsel and Chief Administrative Officer, stated, “We are pleased with the Court’s decision to affirm the dismissal. As an organization focused on improving patient care, we look forward to driving continued innovation in the growing markets we serve.”
MIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX is dedicated to providing a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. The Company’s vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life. For additional information, please visit www.mimedx.com.
Frequently Asked Questions
What lawsuit was dismissed against MIMEDX?
A 2019 securities class action lawsuit was dismissed by the court.
Who affirmed the dismissal of the MIMEDX lawsuit?
The Eleventh Circuit Court of Appeals affirmed the dismissal.
What is MIMEDX focused on?
MIMEDX focuses on improving patient care and healing solutions.
What sectors does MIMEDX serve?
MIMEDX serves wound care, burn, and surgical sectors.
How long has MIMEDX been in business?
MIMEDX has over a decade of experience in healing solutions.